Transient, early release of glucagon-like peptide-1 during low rates of intraduodenal glucose delivery

Regulatory Peptides

Volumn 146, Issue 1-3, 2008, Pages 1-3

  Kuo, Paul ^a   Chaikomin, Reawika ^a   Pilichiewicz, Amelia ^a   O'Donovan, Deirdre ^a   Wishart, Judith M ^a   Meyer, James H ^a   Jones, Karen L ^a   Feinle Bisset, Christine ^a   Horowitz, Michael ^a   Rayner, Christopher K ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

GIP; GLP 1; Incretin; Insulin

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; INSULIN;

ADULT; ARTICLE; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; STOMACH EMPTYING;

ADULT; BLOOD GLUCOSE; DUODENUM; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HUMANS; INSULIN; INTESTINE, SMALL; INTUBATION, GASTROINTESTINAL; MALE; RETROSPECTIVE STUDIES;

EID: 38149140788     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2007.09.032     Document Type: Article

References (18)

1. Efendic S., and Portwood N. Overview of incretin hormones. Horm Metab Res 36 (2004) 742-746
2. Meier J.J., and Nauck M.A. The potential role of glucagon-like peptide 1 in diabetes. Curr Opin Investig Drugs 5 (2004) 402-410
3. Deacon C.F. What do we know about the secretion and degradation of incretin hormones?. Regul Pept 128 (2005) 117-124
4. Schirra J., Katschinski M., Weidmann C., et al. Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest 97 (1996) 92-103
5. Chaikomin R., Doran S., Jones K.L., et al. Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects. Am J Physiol Endocrinol Metab 289 (2005) E504-E507
6. O'Donovan D.G., Doran S., Feinle-Bisset C., et al. Effect of variations in small intestinal glucose delivery on plasma glucose, insulin, and incretin hormones in healthy subjects and type 2 diabetes. J Clin Endocrinol Metab 89 (2004) 3431-3435
7. Horowitz M., Edelbroek M.A., Wishart J.M., and Straathof J.W. Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects. Diabetologia 36 (1993) 857-862
8. Pilichiewicz A.N., Chaikomin R., Brennan I.M., et al. Load-dependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men. Am J Physiol Endocrinol Metab 293 (2007) E743-E753
9. Horowitz M., Cunningham K.M., Wishart J.M., Jones K.L., and Read N.W. The effect of short-term dietary supplementation with glucose on gastric emptying of glucose and fructose and oral glucose tolerance in normal subjects. Diabetologia 39 (1996) 481-486
10. Herrmann C., Goke R., Richter G., Fehmann H.C., Arnold R., and Goke B. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion 56 (1995) 117-126
11. Rayner C.K., Park H.S., Wishart J.M., Kong M., Doran S.M., and Horowitz M. Effects of intraduodenal glucose and fructose on antropyloric motility and appetite in healthy humans. Am J Physiol Regul Integr Comp Physiol 278 (2000) R360-R366
12. Theodorakis M.J., Carlson O., Michopoulos S., et al. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. Am J Physiol Endocrinol Metab 290 (2006) E550-E559
13. Tolessa T., Gutniak M., Holst J.J., Efendic S., and Hellstrom P.M. Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin. J Clin Invest 102 (1998) 764-774
14. Kellett G.L., and Brot-Laroche E. Apical GLUT2: a major pathway of intestinal sugar absorption. Diabetes 54 (2005) 3056-3062
15. Kellett G.L., and Helliwell P.A. The diffusive component of intestinal glucose absorption is mediated by the glucose-induced recruitment of GLUT2 to the brush-border membrane. Biochem J 350 Pt 1 (2000) 155-162
16. Byrne M.M., Pluntke K., Wank U., et al. Inhibitory effects of hyperglycaemia on fed jejunal motility: potential role of hyperinsulinaemia. Eur J Clin Invest 28 (1998) 72-78
17. Little T.J., Doran S., Meyer J.H., et al. The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposed. Am J Physiol Endocrinol Metab 291 (2006) E647-E655
18. Vilsboll T., Krarup T., Deacon C.F., Madsbad S., and Holst J.J. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes 50 (2001) 609-613